CIGB-300

Description: CIGB-300 (P15-Tat) is an anti-casein kinase 2 (CK2) peptide that exhibits anticancer properties by disrupting the phosphorylation activity of protein kinase CK2. The compound induces apoptosis in various tumor cell lines, making it valuable for research in cancer therapy. Target: Casein Kinase. Smiles: C(C=1C=2C(NC1)=CC=CC2)[C@H]3C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N4[C@](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@]([C@@H](C)O)(C(=O)N[C@H](C(O)=O)CSSC[C@H](NC(CCNC([C@@H](NC(=O)[C@H]6N(C(=O)[C@H]7N(C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCCNC(=N)N)NC(CN)=O)=O)CCCCN)=O)CCCCN)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCC(N)=O)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCC7)CCC6)CCC(N)=O)=O)=O)C(=O)N3)[H])(CCC4)[H]